Esthesioneuroblastoma: Outcomes After Treatment
- Conditions
- Esthesioneuroblastoma, Olfactory
- Registration Number
- NCT02580136
- Lead Sponsor
- Ricardo L. Carrau, MD
- Brief Summary
The purpose of this study is to collect and organize data into a repository to gather relevant information for future research from patients diagnosed with a rare malignant sinonasal cancer called esthesioneuroblastoma (ENB) and are scheduled to undergo endonasal skull base surgery. Data being collected includes surgical data, demographics, disease presentation, MRI, CT, PET imaging, and post-operative assessments including pathology tests. After surgery, the investigators will collect chemotherapy and radiation data. Participants will also complete quality of life questionnaires at their follow-up visits.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Between the age of 10-80 years
- Diagnosed with esthesioneuroblastoma
- Refusal to participate
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of Life up to 120 months after treatment Anterior Skull Base (ASB); Skull Base Inventory (SBI); Multidimensional Disease Specific Inventory MDS; ASB-Nasal 12; Sino-Nasal Outcome Test (SNOT-20)
Progression-free survival and overall survival Up to 120 months Kaplan-Meier survival curves
- Secondary Outcome Measures
Name Time Method Length of Hospital Stay up to 120 months Number of participants with intraoperative complications up to 120 months Number of participants with postoperative complications up to 120 months Time spent in operating room up to 120 months MRI imaging evidence of resection up to 120 months Surgical Technique up to 120 months
Trial Locations
- Locations (1)
The Ohio State University
🇺🇸Columbus, Ohio, United States